MediMabBio

Website

Developer of healthcare immunotherapies designed to treat serious diseases such as cancer and autoimmune disorders. The company offers engineered monoclonal antibodies, cytokine-antibody fusion protei...

Healthcare
Seongnam, South Korea
Founded 2017
16 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$37.9M
Last Round
N/A
Investors
+19 other investors
View all 19 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock MediMabBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required